Tectonic Therapeutics TECX Financing Cash Flow
Financing Cash Flow at other companies
Other financials
Where this comes from
Reported directly by Tectonic Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInFinancingActivities.
The official record: Tectonic Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Tectonic Therapeutics's financing cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Tectonic Therapeutics's financing cash flow?
- Tectonic Therapeutics (TECX) reported financing cash flow of $847K in Q1 2026.
- How has Tectonic Therapeutics's financing cash flow changed year-over-year?
- Tectonic Therapeutics's financing cash flow decreased by 99.5% year-over-year, from $178.12M to $847K.
- What is the long-term trend for Tectonic Therapeutics's financing cash flow?
- Over 2 years (2021 to 2023), Tectonic Therapeutics's financing cash flow has grown at a 5.4% compound annual growth rate (CAGR), from $30.37M to $33.75M.
- What does financing cash flow mean?
- Total net cash provided by or used in financing activities — debt issuance/repayment, equity transactions, and dividend payments.